GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
2.310
-0.060 (-2.53%)
Jan 21, 2025, 4:00 PM EST - Market closed
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $5.16 million as of January 21, 2025. Its market cap has decreased by -51.13% in one year.
Market Cap
5.16M
Enterprise Value
-1.08M
1-Year Change
-51.13%
Ranking
Category
Stock Price
$2.31
Market Cap Chart
Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $5.16M, a decrease of -99.45%. That is a compound annual growth rate of -11.84%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 661.30B |
| UnitedHealth Group | 482.33B |
| Johnson & Johnson | 355.85B |
| Novo Nordisk | 355.58B |
| AbbVie | 304.06B |
| Merck & Co. | 244.16B |
| Thermo Fisher Scientific | 219.51B |
| Intuitive Surgical | 214.54B |